#migraines #drugresearch

The drug atogepant may help prevent migraines for people who have had no success with
other preventive drugs, according to a preliminary study released April 20, 2023, which will be
presented at2 the American Academy of Neurology’s 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023. The study involved people with episodic migraine, which is defined as having up to 14 headache days per month with migraine
characteristics. Atogepant is a calcitonin gene-related peptide receptor antagonist or CGRP inhibitor. CGRP is
a protein that plays a key role in starting the migraine process.

Get the latest medical and health news at medicaldialogues.in
Follow us on
Twitter: https://twitter.com/medicaldialogs
Facebook: https://www.facebook.com/medicaldialogues/
Instagram: https://www.instagram.com/medicaldialogues
LinkedIn: https://www.linkedin.com/company/medical-dialogues
Website: https://medicaldialogues.in/

0 Comments

Up next

Autoplay

First look at Eblyss - @EliLillyandCompany a new drug for the treatment of atopic dermatitis

1 Views . 08/29/25 Side Effects

Please note that if you are under 18, you won't be able to access this site.

Up next

New drug may help prevent migraine for difficult cases

Up next

Language